Stocks To Buy Now Blog

All posts by Christopher

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Advances Efforts to Launch Ukrainian Iron Project as Market Prices Continue to Rise

  • Black Iron is working to fund the launch of its wholly owned Ukrainian iron ore project by the end of the year, recently closing a more than $1.5 million private placement
  • Iron ore market prices continue climbing amid supply setbacks elsewhere in the world, and some analysts anticipate the possibility of $100 per metric ton soon
  • Ukraine’s Kryvyi Rih region is one of the country’s most prolific for iron deposits, spawning a number of mines and processing facilities

Mine developer Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) continues to foresee a great potential opportunity in rising iron market prices as the company’s 100 percent-owned development project in Ukraine’s Kryvyi Rih region tries to secure essential land and funding for construction, and its efforts are gaining national media attention.

Black Iron’s work to start building a mine operation at its Shymanivske project is held up by the need to obtain the surface rights at the central Ukraine site. This includes land held by Ukraine’s Ministry of Defense (“MOD”) that is directly adjacent to Black Iron’s ore body. The MOD uses the site for training purposes, but it is in discussion with company management to relocate some of its facilities to free up sufficient land to meet Black Iron’s needs.

Iron ore prices have been on an upward trajectory because of production cutbacks related to short-term adverse natural events in Australia and the apparently longer-term disruptions in Brazil caused by the failure of a tailings dam at the beginning of the year and subsequent concerns about other dams in the region. Ongoing legal hurdles have continued to drive down output forecasts amid unsuccessful Vale SA (NYSE: VALE) efforts to resume iron ore operations (http://ibn.fm/jpzxN), fueling projections that iron ore could soon top $100 per metric ton.

Toronto-based industry publication The Northern Miner has followed developments in Kryvyi Rih, and last year’s report (http://ibn.fm/1JtWC), titled ‘Site visit: Black Iron advances Shymanivske premium iron ore project in Ukraine’, has been selected as a finalist in the inaugural National Magazine Awards launched by the National Media Awards Foundation to recognize excellence in business-to-business (B2B) journalism.

A panel of 62 judges nominated 95 entries from 34 B2B publications in more than a dozen categories, and the article on Black Iron’s progress is listed among nine finalists for the ‘Best Profile of a Company’ award (http://ibn.fm/1b1Qa). The winners will be announced on May 29 at the awards luncheon at Toronto’s One King West Hotel. Black Iron applauds reporter John Cummings for this story and wishes him luck at the awards.

Kryvyi Rih is one of Ukraine’s largest centers of metallurgical activity. The 62-mile long city is ringed by quarries, iron mines, steel and coke-processing facilities, given the region’s rich iron ore deposits. Black Iron has completed a NI 43-101-compliant resource report and a preliminary economic assessment, which estimates that the site has 646 million tons of measured and indicated mineral resources, plus 188 million tons of inferred resources supporting a 20-year mine life.

In April, the company upsized and closed the final tranche of a non-brokered private placement funding effort to raise over $1.5 million in favor of the project, which was labeled the lowest-cost undeveloped pellet feed project globally by metals consultancy CRU (http://ibn.fm/AMg9w). The main use of proceeds from this raise will be to secure funding from institutional investors that have expressed interest in backing construction of Black Iron’s Shymanivske project and land surface rights for the mine, concentrator, tailings and waste rock piles.

For more information, visit the company’s website at www.BlackIron.com

NOTE TO INVESTORS: The latest news and updates relating to BKIRF are available in the company’s newsroom at http://ibn.fm/BKIRF

City View Green Holdings Inc. (CSE: CVGR) Signs LOI, Seeks to Establish Facility as Key Cannabis Grow-and-Extraction Property

  • CVGR anticipates closing the transaction within 60 days
  • Terms of the deal call for the new landlord to finance required buildout and capital improvements
  • CVGR has a seed-to-retail model designed to grow and produce high-quality cannabis extracts and edible products

City View Green Holdings Inc. (CSE: CVGR) hopes to close on its letter of intent (LOI) for a purchase leaseback transaction of its Brantford, Ontario, facility and property within 60 days. Terms of the LOI call for the new landlord to finance the buildout and capital improvements required for CVGR to obtain Health Canada licenses. After the licenses are obtained, CVGR anticipates creating an operational cannabis grow-and-extraction facility (http://ibn.fm/Iqhya).

The agreement notes that CVGR would exercise its option to purchase the Brantford property then transfer that option to a financier. CVGR would then enter a five-year lease with a five-year renewable term. The company would have the right of first refusal to purchase the facility and property if the new owner decides to sell.

“This is a nondilutive way for us to finance and finalize the required buildout of the Brantford facility,” CVGR CEO Ian MacDonald said in a news release. “We are confident we have established the framework for a mutually beneficial outcome with the financier. We hope to have this deal closed within the next 60 days, and our current buildout initiatives are proceeding as planned.”

Toronto, Ontario-based CVGR is a vertically integrated seed-to-sale cannabis company planning to grow high-quality cannabis and produce extracts. The company anticipates producing edible products, distillates and water-soluble products for the beverage market, once those products are legalized. CVGR is focused on becoming a diversified company that will potentially acquire targets in the cannabis industry.

For more information, visit the company’s website at www.CityViewGreen.ca

NOTE TO INVESTORS: The latest news and updates relating to CVGR are available in the company’s newsroom at http://ibn.fm/CVGR

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) Provides Strategic Update on Growth Plan, Announces Name Change

  • In a strategic update, Innovative Properties Inc. d/b/a Nabis Holdings announced shareholder approval for a name change
  • Nabis also presented key strategic developments, like the acquisition of various cultivation and processing properties in the U.S. and an increase in its number of board directors
  • The Nabis managerial team will also be working on establishing the company’s reputation through participation in the Third Annual Canaccord Genuity Cannabis Conference

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, announced on May 6, 2019, that company shareholders had approved a name change to Nabis Holdings, subject to Candian Securities Exchange approval (http://ibn.fm/U1kfG). In addition, the company provided a strategic update on its growth plan.

Nabis CEO and Director Shay Shnet said in the update that the company has been working diligently to identify vertically integrated cannabis assets that are worthy of investment. These assets operate primarily in the U.S., in limited license states that already have well-established markets (Arizona, Michigan, California, Nevada and Massachusetts).

Additionally, the company enhanced its board to six directors, Shnet said. The managerial team will maintain its commitment to expanding the Nabis portfolio, with a focus on businesses with operational experience and pharma-grade quality products for both the medicinal/wellness and recreational markets.

Earlier, Nabis Holdings announced its Depository Trust Company (DTC) eligibility for the U.S. markets (http://ibn.fm/ihkgN). This is yet another step that has furthered the company’s investment appeal, Shnet noted. He also said that “the ability for investors to electronically transfer between brokerages in the U.S. is significantly more convenient and provides to existing investors the benefit from greater liquidity and execution speeds, while attracting new investors to gain access that may have been previously restricted from investing in Nabis.”

The Canadian investment company has also provided a few additional highlights as part of publicly disclosing its strategic growth plans. In March 2019, Nabis completed a private placement offering that generated gross proceeds of $35 million.

In addition, Nabis completed five strategic investments in properties, as well as cultivation and processing licenses. The acquisition of these properties will enable Nabis to get started with indoor, outdoor and greenhouse cannabis cultivation.

To further cement its position and establish its reputation in the cannabis field, the company has also taken up participation in industry events like the Third Annual Canaccord Genuity Cannabis Conference (http://ibn.fm/2LxIl).

The conference took place on May 14 at the Grand Hyatt New York in New York City. Shnet held a presentation during the event. Additionally, one-on-one meetings with the Nabis management were available.

Nabis Holdings focuses on strategic revenue generation, and, while its interests span various industries, high quality cannabis companies in the U.S. represent a major interest. Once an acquisition is completed, Nabis employs a hands-on approach to ensure optimization of operations. The company has so far entered into binding letters of intent to invest in various vertically integrated assets in Michigan, Arizona and Washington State.

For more information, visit the company’s website at www.NabisHoldings.com

NOTE TO INVESTORS: The latest news and updates relating to INNPF are available in the company’s newsroom at http://ibn.fm/INNPF

ChineseInvestors.com Inc.’s (CIIX) Pop-Up Store Strategy Offers Unique Retail Branding, Shopping Intimacy

  • CIIX’s Q3 2019 revenue was driven by hemp and CBD product sales, generating $1.1 million of the quarter’s $1.4 million in sales
  • CIIX subsidiary Chinese Wellness Center launched a pop-up store in California’s Glendale Galleria Mall
  • Forbes reports that pop-up stores provide an intimate experience, create awareness and drive a unique shopping experience

ChineseInvestors.com Inc.’s (OTCQB: CIIX) wholly owned Chinese Wellness Center (“CWC”) subsidiary entered a new wave of retailing when it debuted a pop-up store in the Glendale Galleria Mall in California earlier this month. The store showcases its own opt line of industrial hemp/CBD products. These products drove Q3 2019 CIIX sales, delivering $1,061,318 of the $1,444,822 reported for the quarter. A 81 percent YOY revenue increase was achieved by CIIX in the period (http://ibn.fm/GoCxu).

In addition to the opt line, the pop-up store carries industrial hemp/CBD products such as NuLeaf Naturals, Joy Organics, Medterra, HempMeds and Medix. The store also offers special deals, promotions and giveaways for Glendale Galleria customers.

“Building on the current success of CWC’s industrial hemp/CBD product offerings, this pop-up kiosk will allow us to further engage with our local customers beyond our online presence,” CIIX CEO Warren Wang stated in a news release (http://ibn.fm/o3im9).

Forbes reports that pop-up stores enable retailers to be more intimate with customers when they launch new products. Online shopping is quick but remote compared to the creativity and uniqueness of pop-up shopping, the report notes. Online, consumers cannot try before they buy. “Pop-up shops [are]… where brands can get intimate with consumers and immerse them in a vibe,” reads the report (http://ibn.fm/VGz2u). “If you aren’t entering a new market but still want to generate brand buzz, a pop-up can be the way to go.”

The Shopify Plus site says that pop-ups fall between online and big box brick-and-mortar shopping experiences. “Pop-up shops are growing in popularity as a ‘hybrid model’ to build more intimate relationships while creating unique, memorable 3D experiences that are aligned with the brand’s values,” the site notes (http://ibn.fm/14gW0). Entrepreneur.com calls pop-ups a 2019 trend that draws in customers and experiments in retail (http://ibn.fm/Q3240).

Deloitte’s ‘2019 Consumer Products Outlook’ report found that pop-up stores can educate consumers about a product, create customers and generate brand awareness (http://ibn.fm/9dtKB). The unique stores can also add excitement to the shopping experience, as compared to a traditional retail store.

CIIX is a diverse company that offers its audience of Chinese-speaking investors real-time market commentary, analysis and education-related services in Chinese character language sets. During the quarter, the company consolidated its e-commerce sites to offer a one-stop shopping experience through its website, www.365CWC.com.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

Spectrum Global Solutions Inc. (SGSI) Projects Increased 2019 Revenues

  • After growing revenues to $34.5 million, SGSI says that it is in an advantageous position to win more contracts
  • SGSI has received more than $3.7 million in new contracts to support carrier network upgrades
  • SGSI CEO sees accelerated growth for the company in 5G implementation

Spectrum Global Solutions Inc. (OTCQB: SGSI) projects its volume to increase in 2019, based on a combination of organic growth and post-accretive acquisitions. SGSI is a single-source provider of wireless and wireline network infrastructure and professional service solutions to the service provider (carrier) and corporate enterprise markets (http://ibn.fm/XxYGp).

SGSI CEO and Chairman Roger Ponder said in a news release that the company’s future growth would stem in large part from the implementation of 5G, network upgrades and the installation of millions of “small cells.” The company’s sales in 2018 grew to $34.5 million from $10.8 million in 2017, and SGSI is in an advantageous position to win more contracts versus competitors that are unable to meet service provider criteria (http://ibn.fm/MQ5Yu). SGSI has received more than $3.7 million in new contracts to support carrier network upgrades.

“Attention about 5G has been focused on the publicly announced plans of major telecom companies to install millions of ‘small cells’ on electric utility poles, on public buildings and schools, on bus stop shelters, in public parks and other public and private owned infrastructure,” Ponder said in a news release. “All these ‘small cells’ will require new fiber connections to transmit the ever-increasing data being consumed. These plans provide tremendous new opportunities in both engineering and installation services for our company.”

Commenting on the $3.7 million in new work orders, Ponder added, “These work orders from new and existing clients continue to show the accelerated growth predicted as a result of national 5G implementations and ongoing network upgrades that have begun this year.”

SGSI is a leading provider of telecommunications engineering and infrastructure services in the United States, Puerto Rico, Canada, Guam and the Caribbean. The company’s investor presentation says that expanding its service footprint and offering new services enable SGSI to provide a deeper, wider breadth of services.

For more information, visit the company’s website at www.SpectrumGlobalSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to SGSI are available in the company’s newsroom at http://ibn.fm/SGSI

City View Green Holdings Inc. (CVGR) Sees Bright Future in Recreational Cannabis Products

  • Demand for recreational cannabis has outpaced supply in Canada
  • City View Green is retrofitting a 40,000-square-foot building to the highest standards for premium growth and extraction
  • The company has secured a master grower and expert extraction team to grow high-quality flower and produce superior-grade cannabis extracts

City View Green Holdings Inc. (CSE: CVGR) is a vertically integrated cannabis company focused on seed-to-retail offerings. The company’s goal is to be a leading purveyor of medicinal and recreational cannabis while providing the most comprehensive and customer-centric user experience and creating a well-diversified company capable of producing long-term results.

The demand for what CVGR offers within the recreational market in Canada alone has outpaced the supply. Only one month following legalization in Canada, consumers were warned to expect cannabis products to be sold out across the country (http://ibn.fm/O27o4). According to ArcView Market Research, the recreational market is estimated to be valued at $3 billion by 2021, achieving a projected compound annual growth rate of 78 percent from 2018 to 2021. Deloitte suggests that cannabis may outsell the combined beer, wine and spirits industry, while a potential economic impact of both medical and recreational is forecast to reach over $22 billion (http://ibn.fm/L2FoL).

CVGR is working within this quickly growing industry to help curate the cannabis experience for the recreational market consumer and provide guidance for established and new retailers. CVGR sees a strong future in recreational cannabis products and is positioned to produce high-quality edibles, distillates and water-soluble products for the beverage market. Having secured a master grower, the company will be growing a high-quality crop to create its own superior-grade cannabis extracts.

A 40,000-square-foot growing facility is in the planning stages in Brantford, Ontario. The property is being retrofitted to the highest standards for premium grow operations, which includes state-of-the-art LED lighting, HVAC, dehumidification systems and automation technologies. A 4,000-square-foot extraction lab will feature an ultra-efficient CO2 supercritical extraction process. The chosen supercritical fluid extraction equipment offers proven consistent results and the highest yields, with no degradation of materials.

“The equipment we have selected has been successfully used for a quarter century in fluid extraction, and their methods have been applied to over 600 natural oils and compounds from over 300 different bio-botanical raw materials,” Mike Hagopian, CVGR’s chief operations officer and extraction guru, stated in a news release. “We are very confident this equipment will establish us as a leader in the processing of high-quality THC and CBD extracts.”

While other companies focus mainly on crop yield, CVGR is also working to lower production costs while creating and refining extraction and processing methodologies. Utilizing the skill of a master grower and an expert extraction team, the company is focused on providing superior-grade cannabis products that utilize the entire plant, making the multitude of experiential and healing modalities that it offers readily available to consumers.

CVGR is focused on providing quality every step of the way. Utilizing premium growing operations and the highest-quality fluid extraction equipment, the company is committed to offering superior products to the consumer.

For more information, visit the company’s website at www.CityViewGreen.ca

NOTE TO INVESTORS: The latest news and updates relating to CVGR are available in the company’s newsroom at http://ibn.fm/CVGR

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) Out to Build Private Equity Colossus in Cannabis Space

  • Nabis Holdings is a private equity play with global ambitions in the cannabis space
  • The company has cannabis investments in Arizona, Michigan and Washington
  • INNPF’s management team boasts a track record of boosting valuations

With the establishment of Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P), Shay Shnet and Mark Krytiuk seem set for an encore. The pioneering pair are co-founders of MPX Bioceutical (CSE: MPX) and played important roles prior to its merger with iAnthus Capital Holdings Inc. (OTCQX: ITHUF), valued at C$835 million. Now, Shnet and Krytiuk are out to repeat that success with Nabis Holdings, an aptly named investment entity; the name means “repeat performance.” Nabis is targeting vertically integrated cannabis companies with positive EBITDA that are operating in limited license states with large addressable markets.

MPX Bioceutical was founded by Shnet and Krytiuk to focus on developing and operating assets across the global cannabis industry. Shnet, with two decades of experience in senior management roles under his belt, served as vice president of operations and led the company’s efforts to build a portfolio of international cannabis assets. He is especially adept in unearthing unique investment opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines. Mark Krytiuk was vice president of grow operations at MPX Bioceutical and, in that position, supervised the production of medical marijuana and pharma-grade products across North America. Moreover, he has been directly involved in the construction of nine cannabis facilities in three different countries, with budgets ranging up to $30 million.

The dynamic duo has already set the ball rolling. Nabis has executed binding letters of intent (LOI) to invest in the states of Michigan, Arizona and Washington. In Michigan, Nabis plans to invest in seven strategically located properties that have or are eligible for municipal approvals as provisioning centers. In addition, the company plans to acquire a municipally approved property with 10 cultivation licenses and one processing license.

In Arizona, Nabis has executed a binding LOI to acquire full control of Organica Patient Group Inc. (“OPG”) and RDF Management Group (“RDF”). OPG is a fully-integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its operations include the Chino Valley MMJ Dispensary, a 26,000 square foot indoor cultivation and processing center and a 56,600 square foot greenhouse. OPG has its own branded products and an extensive distribution network that covers more than 25 percent of dispensaries in Arizona.

In Washington, Nabis plans to purchase assets from PDT Technologies LLC (“PDT”), which include extraction and production equipment and rights to lease a current production facility. With the acquisition, Nabis will enjoy licensing rights to produce Chong’s Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space.

On completion of its proposed acquisitions, Nabis is shooting for revenues of C$12 million in 2019 and C$116 million by 2020, at a gross margin of 55 percent. Expected EBITDA is forecast at C$3.3 million for 2019 and C$39.4 million for 2020.

For more information, visit the company’s website at www.NabisHoldings.com

NOTE TO INVESTORS: The latest news and updates relating to INNPF are available in the company’s newsroom at http://ibn.fm/INNPF

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) En Route to Becoming the Leading Global Provider of Organic Cannabis

  • A zoning settlement for the company’s cannabis greenhouse in Ontario is finalized and approved
  • The company’s supply agreement with British Columbia has been signed
  • TGOD entered the U.S. market through a cornerstone investment in Califormulations LLC
  • The company will release first quarter 2019 earnings results after market close on May 14, 2019, and will hold a webcast before market open on May 15, 2019

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) seems to have all the right boxes ticked as it pursues a relentless quest to become the world’s leading provider of organic cannabis. Licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), the Hamilton, Ontario-based company has a planned global capacity of 219,000kg and is building 1,643,000 sq. ft of cultivation and processing facilities across Canada and Jamaica, with the option to expand further in Denmark. That planned production moved closer to actuality after the company got the green light for its proposed greenhouse in Ancaster, Ontario. Product cultivated in this new facility likely won’t stay in inventory for long. TGOD recently signed a supply agreement with the British Columbian government, in addition to the company’s next move, entering the U.S. CBD beverage market. TGOD plans to release its first quarter 2019 earnings results after market close on May 14, 2019, and it will host an earnings call on May 15, 2019, at 9:00 am ET (http://ibn.fm/o6ICV).

TGOD has confirmed that it has finalized and signed a settlement offer with the Hamilton City Council, which was approved by the Local Planning Appeal Tribunal at a meeting on May 2, 2019 (http://ibn.fm/5ZIpf). Its proposed greenhouse in Ancaster, Ontario, designed for the production of premium certified organic cannabis, will have an annual capacity of 17,500kg. Lying close to Niagara, Ancaster is known for its easily accessible water power, which makes electricity generation relatively inexpensive. The company has an agreement with Eaton Corp., the $36 billion global power management company, under which Eaton, by providing research and optimization, will allow TGOD to have some of the lowest electricity input costs in the business. As a result, the Ontario facility is expected to produce at a power rate of $0.045 k/Wh, while the Quebec operation will produce at a power rate of $0.035 k/Wh.

The company has already secured the Ontario market. Earlier this year, TGOD signed an agreement with the Ontario Cannabis Retail Corporation (“OCRC”) (http://ibn.fm/bl0n6). The OCRC is a Canadian Crown corporation, established to be a monopoly, which operates the only legal online store for recreational cannabis in Ontario. The OCRC is set to become the wholesaler of cannabis for private retail stores in the province of Ontario.

TGOD has signed a similar deal with the government of British Columbia (http://ibn.fm/h5QJG). The company recently announced a cannabis supply agreement with the British Columbia Liquor Distribution Branch (“BCLDB”). The BCLDB, under the brand ‘BC Cannabis Stores’, is British Columbia’s public retailer of non-medical cannabis. “To negotiate the agreement, TGOD partnered with Velvet Management Inc., a wholly owned subsidiary of Phillipe Durand Wines, one of Canada’s prominent wine distributors. Velvet Management, through Phillipe Dandurand Wines, provides TGOD with national sales and distribution capabilities to provincial liquor and cannabis boards.”

TGOD has also announced its entry into the U.S. beverage market (http://ibn.fm/4BS1D). “The Company has established a joint partnership, Califormulations LLC, with Symrise AG, a global supplier of a global supplier of fragrances, flavorings, raw materials, as well as functional & cosmetic active ingredients.” The new subsidiary, which will be based in Columbus, Georgia, will provide global branded companies with concept-to-shelf beverage commercialization support, including formulation development, technical services, in-house pilot scale production and contract manufacturing coordination. Califormulations will also expedite and facilitate the U.S. launch of TGOD-branded organic hemp-based CBD beverages.

For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Adds Four Members to Advisory Board, Renews Executive Contracts

  • LXRP recently added multiple highly respected experts to its scientific advisory board
  • The company is readying for growth by ensuring executive continuity
  • LXRP continues to conduct research regarding oral nicotine

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has bolstered its future growth prospects by adding four new members to its scientific advisory board and renewing executive contracts with three-year compensation deals for key officers, including CEO Chris Bunka and President John Docherty. The agreements and new advisory board team members offer LXRP and its shareholders seamless executive continuity (http://ibn.fm/oBuUZ).

New members of LXRP’s scientific advisory board include (http://ibn.fm/KSdJ3):

  • Dr. Dwayne Godwin, dean of the graduate school and professor in the Departments of Neurobiology and Anatomy at the Institute for Regenerative Medicine at Wake Forest University;
  • Dr. Terry D. Blumenthal, professor of psychology and neuroscience at Wake Forest University;
  • Dr. Matthew Fraser, an associate professor and director of basic science research in the Department of Surgery, Division of Urology, at Duke University Medical Center; and
  • Dr. Carla Lema Tome, an industry consultant and adjunct assistant professor of neurobiology and anatomy at Wake Forest University School of Medicine.

“Lexaria Bioscience Corp. is very pleased to welcome these accomplished experts to our Advisory Board,” Bunka stated in a news release. “[They] can provide critical scientific guidance to Lexaria’s ongoing and future R&D programs. Lexaria is building towards becoming one of the world’s leaders in drug delivery technology, and our most recent advisors can assist in achieving that goal.”

In addition, the new three-year executive agreements offer both Bunka and Docherty compensation and bonuses based on meeting certain performance criteria, as established by LXRP’s board.

Based in British Columbia, Canada, LXRP is a biotechnology company and drug-delivery platform innovator. DehydraTECH is the company’s proprietary absorption technology platform. LXRP has developed and out-licenses its disruptive technology, which promotes healthier ingestion methods and lower overall dosing. LXRP is conducting research for DehydraTECH’s potential applications for oral nicotine absorption (http://ibn.fm/HGStA). LXRP holds a patent for oral delivery of all cannabinoids.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

Cannabis Strategic Ventures Inc. (NUGS) Expands Portfolio in California’s Cannabis Space

  • Cannabis Strategic Ventures is dedicated to supporting entrepreneurial growth in California’s cannabis industry through acquisitions and partnerships
  • California’s cannabis industry is the world’s largest market for the plant’s products, with expected sales revenues of $7.7 billion by 2022
  • NUGS subsidiary Asher House gained prominent media attention this month after an appearance on the Ellen DeGeneres show

California’s pioneering entry into the medical cannabis and recreational marijuana industries continues to attract challenges, as exemplified through recent concerns over an expected supply shortage when some 10,000 cultivators’ temporary state licenses expired at the end of April (http://ibn.fm/pRWVF).

As California’s legal infrastructure struggles to find a solution to keep businesses operating legally and to stave off costly lawsuits, companies such as Los Angeles-based Cannabis Strategic Ventures Inc. (OTC: NUGS) that have placed a priority on holding licenses that keep them in the state’s good graces are positioned to weather the regulatory storms with a corporate calm that allows them to focus all of their efforts on core mission fundamentals.

NUGS’ year began with announcements that it would partner with a Santa Barbara County cultivator that holds about 40 commercial cannabis licenses (http://ibn.fm/Pl02v) and that NUGS has also garnered over 20 licenses for cannabis cultivation, manufacturing and distribution, allowing it to proceed with breaking ground on a six-acre Northern California canopy cultivation site known as The NUGS Farm (http://ibn.fm/R5Vux), establishing a presence for the company at both ends of the state.

“Establishing The NUGS Farm and securing these licenses are significant milestones for Cannabis Strategic Ventures,” CEO Simon Yu stated in a news release. “We are proud of what we have accomplished at this stage of the company. As the cannabis industry expands, and as we work to make cannabis legal on a federal level, Cannabis Strategic Ventures will be in position to touch on all areas of cannabis production.”

Cannabis Strategic Ventures is focused on supporting entrepreneurial growth within the legal cannabis sector, which has gained an explosive degree of popularity and social awareness in North America during recent years. The company is building a portfolio of varied subsidiaries and, in February, gained a boost to that end from an investment of up to $3 million from a university student initiative known as Triton Funds, announced as effective once an upcoming S1 registration statement is completed.

One company subsidiary benefitted in April from significant media attention after Luke Barton and Lee Asher of the Asher House shelter dog adoption enterprise appeared on the Ellen DeGeneres show and were honored for their efforts to help pets find homes, receiving a $10,000 check from DeGeneres’ ally, ShutterFly Inc. (http://ibn.fm/uLlAH), as well as news coverage following the appearance (http://ibn.fm/5x4Ym). Asher House joined the Cannabis Strategic Ventures team last year when NUGS acquired a controlling interest in Asher House’s Pet CBD line of hemp-derived cannabidiol supplements (http://ibn.fm/vwvvo).

California remains the world’s largest cannabis market, and researchers at BDS Analytics forecast that sales of cannabis will hit $5.1 billion this year in the state (http://ibn.fm/Zw6Y0). Continuing this trend, Cannabis Business Plan analysts predict that the state industry will reach $7.7 billion in annual revenues by 2022 (http://ibn.fm/WhCUE).

For more information, visit the company’s website at www.CannabisStrategic.com

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Strengthens Rare Disease Pipeline Program Through UK Regulatory Innovation Designation

March 20, 2026

Regulatory recognition from international health authorities can significantly shape the trajectory of emerging therapies worldwide, particularly in rare disease development where clinical pathways are often complex and resource intensive. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases and unmet medical needs, recently received such recognition as its […]

Rotate your device 90° to view site.